1 / 11

Dr Chris Henshall President, HTAi

HTA: political and ethical perspectives Presentation to Forum on Pharmaceutical Policy in the Enlarged Europe at 7 th European Health Forum Gastein, Austria, 7 October 2004. Dr Chris Henshall President, HTAi Honorary Professor, London School of Hygiene and Tropical Medicine

vine
Download Presentation

Dr Chris Henshall President, HTAi

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HTA: political andethical perspectivesPresentation to Forum on Pharmaceutical Policy in the Enlarged Europe at 7th European Health ForumGastein, Austria, 7 October 2004 Dr Chris Henshall President, HTAi Honorary Professor, London School of Hygiene and Tropical Medicine Group Director, Office of Science and Technology, Department of Trade and Industry, England

  2. HTA is the scientific collection, review and synthesis of information to support informed decisions about health care Health care decisions are made by those accountable for them. Decisions involve judgements and reflect values attached to different goals and outcomes HTA does not make decisions. HTA seeks to inform decisions with science What is HTA?

  3. Patients and clinicians, making individual treatment decisions Clinicians, managers, policy makers and politicians making decisions about the allocation of resources to or within health care, and/or the provision of treatments within institutions and systems Who can use HTA?

  4. Information on probabilities of different outcomes Relevant to their life and interests Personalised for them For all relevant treatment options Help in clarifying their goals and values Help in combining all this information in a complex decision What support doindividual decisions need?

  5. Effectiveness - in terms of all the outcomes of significance to the patient group or population served Cost-effectiveness - in relationship to alternative treatment strategies for target and other patient groups Demands/effects on system – human and other resources required to deliver it Total financial cost to the system – what costs will be driven in and out? What information dosystems-level decisions need?

  6. Relationship to goals and priorities of system, eg Health vs lifestyle Vulnerable or priority groups Other ethical considerations Contribution to progress in health care Indirect effects on well-being of population, eg: employment and wealth creation in health care and other industries; effects on environment Systems-level decisions (2)

  7. Effectiveness Cost-effectiveness Demands/effects on system Total financial cost to the system Relationship to goals and priorities of system Other ethical considerations Contribution to progress in health care Indirect effects How well is HTA doing?

  8. Continuing to work with decision makers in health care industries and systems Understanding the patient perspective Putting the T (back) in HTA Addressing the system level and social and ethical dimensions Widening the skills base Key challenges for HTA

  9. The mission of HTAi is to support the development, communication, understanding and use of HTA around the world as a scientifically based means of promoting the introduction of effective innovations and the effective use of resources in health care Independent from all sectors, the Society provides a single forum for members to share and exchange state-of-the-art ideas related to the development and application of HTA Health Technology Assessment International

  10. Annual scientific and professional meeting – addressing interests of all key constituencies Special interest groups Networking Web based interaction Targeted meetings Developing general web-based resources HTA Portal HTAi Policy Forum HTAi (continued)

  11. chris.henshall@dti.gsi.gov.uk or chris.henshall@blueyonder.co.uk Further information

More Related